Open Orphan #ORPH – Result of General Meeting

Open Orphan is pleased to announce that at the Company’s General Meeting held earlier today in relation to the Company’s proposed merger with hVIVO plc and the Proposed Placing, all of the Resolutions put to the meeting were duly passed. The Board is excited by the growth potential of the Enlarged Group following completion of […]
Alan Green discusses Open Orphan #ORPH, Mirriad Advertising #MIRI and IXICO #IXI on Vox Markets podcast

Alan Green discusses Open Orphan #ORPH, Mirriad Advertising #MIRI and IXICO #IXI with Justin Waite on the Vox Markets podcast.
Open Orphan #ORPH – Pre-Admission Announcement for Euronext Growth Markets

Pre-Admission Announcement Euronext Growth Schedule 1 Announcement to be made by the Applicant prior to admission in accordance with the Euronext Growth Markets Rule Book All Applicants must complete the following Company name Open Orphan plc (“Open Orphan” or the “Company”, and together with its subsidiaries the “Group”) Company registered address and if different, […]
Open Orphan #ORPH – New 3 Year Contract with major Pharmaceutical Company

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the signing of a new 3-year contract with a tier 1 German pharmaceutical company which is one of Europe’s top research-driven pharmaceutical companies. The contract guarantees significant annual revenue with work under the contract to commence this month. This contract sees Venn Life Sciences […]
Ken Baksh January 2020 Market Report

During one-month period to 31st December 2019, major equity markets registered strong gains. The FTSE ALL-World Index rose by 2.18% over the period, up by 23.9% since the beginning of the year. The VIX index fell by 1.45% to end the period at 12.26, a rather “complacent” level by historic standards. Most fixed interest products […]
Tiziana Life Sciences #TILS – Director Dealing, Exec Chairman Gabriele Cerrone purchases 12,500 ADSs

New York/London, 2 January 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on 31 December 2019, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought 12,500 ADSs each representing 5 […]